These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8723016)

  • 21. Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings.
    Sarullo FM; Pasquale PD; D'Alfonso G; Amerigo L; Cannizzaro S; Castello A
    Ital Heart J; 2001 Aug; 2(8):605-11. PubMed ID: 11577835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombolytic therapy for acute ischemic stroke: 3 h and beyond.
    Padma V; Fisher M; Moonis M
    Expert Rev Neurother; 2005 Mar; 5(2):223-33. PubMed ID: 15853492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stenting versus thrombolysis in acute myocardial infarction trial (STAT).
    Indian Heart J; 2001; 53(3):375. PubMed ID: 11516047
    [No Abstract]   [Full Text] [Related]  

  • 24. Coronary thrombolysis. Principles and practice.
    Erhardt L; Emanuelsson H; Hartford M; Johnsson H; Strandberg LE
    Acta Med Scand; 1988; 224(5):413-24. PubMed ID: 2974233
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacological treatment of Raynaud's phenomenon with special reference to calcium-entry blockers.
    Nilsson H
    Acta Pharmacol Toxicol (Copenh); 1986; 58 Suppl 2():137-49. PubMed ID: 2872769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombolysis in fulminant purpura: observations on changes in microcirculatory perfusion during successful treatment.
    Spronk PE; Rommes JH; Schaar C; Ince C
    Thromb Haemost; 2006 Mar; 95(3):576-8. PubMed ID: 16525591
    [No Abstract]   [Full Text] [Related]  

  • 27. [Myocardial reperfusion--a double-edged sword?].
    Peuhkurinen K
    Duodecim; 1989; 105(9):822-30. PubMed ID: 2663424
    [No Abstract]   [Full Text] [Related]  

  • 28. [Protection of the ischemic myocardium].
    Stanciu L; Avram R; Georgescu L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(6):519-28. PubMed ID: 2908155
    [No Abstract]   [Full Text] [Related]  

  • 29. Thrombolytic therapy in the acute management of frostbite injuries.
    Wagner C; Pannucci CJ
    Air Med J; 2011; 30(1):39-44. PubMed ID: 21211711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcium channel antagonists in the modern era of coronary thrombolysis: benefit or detriment?
    Foley JA; Becker RC
    Cardiovasc Drugs Ther; 1996 Sep; 10(4):403-7. PubMed ID: 8924052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombolysis and myocardial salvage. Results of clinical trials and the animal paradigm--paradoxic or predictable?
    Gersh BJ; Anderson JL
    Circulation; 1993 Jul; 88(1):296-306. PubMed ID: 8319343
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prevention of acute coronary occlusion after reperfusion therapy--application of antithrombotic drugs].
    Fujii K
    Nihon Rinsho; 2003 May; 61 Suppl 5():547-51. PubMed ID: 12808999
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug therapy in brain ischaemia.
    Gisvold SE; Steen PA
    Br J Anaesth; 1985 Jan; 57(1):96-109. PubMed ID: 3881117
    [No Abstract]   [Full Text] [Related]  

  • 34. Myocardial stunning: a role for calcium antagonists during reperfusion?
    Opie L
    Cardiovasc Res; 1992 Jan; 26(1):20-4. PubMed ID: 1516108
    [No Abstract]   [Full Text] [Related]  

  • 35. Thrombolytic treatment and new calcium antagonists.
    Feely J; Pringle T; Maclean D
    Br Med J (Clin Res Ed); 1988 Mar; 296(6623):705-8. PubMed ID: 3128377
    [No Abstract]   [Full Text] [Related]  

  • 36. [Efficacy of different therapeutic principles in experimental retinal vessel occlusions].
    Wizemann A; Maier T; Wizemann V
    Fortschr Ophthalmol; 1983; 80(2):176-8. PubMed ID: 6413338
    [No Abstract]   [Full Text] [Related]  

  • 37. What to expect from the newest drugs.
    Rodman MJ
    RN; 1988 Mar; 51(3):59-68, 72-6. PubMed ID: 2895493
    [No Abstract]   [Full Text] [Related]  

  • 38. Peripheral symmetrical gangrene successfully treated with epoprostenol and tissue plasminogen activator.
    Denning DW; Gilliland L; Hewlett A; Hughes LO; Reid CD
    Lancet; 1986 Dec; 2(8520):1401-2. PubMed ID: 2878263
    [No Abstract]   [Full Text] [Related]  

  • 39. Adjunctive therapy in coronary thrombolysis: prostaglandins, nitrates and calcium antagonists.
    Fitzgerald D
    Coron Artery Dis; 1995 Dec; 6(12):940-6. PubMed ID: 8723016
    [No Abstract]   [Full Text] [Related]  

  • 40. Thrombolysis and its sequelae. Calcium antagonists as potential adjunctive therapy.
    Roberts R
    Circulation; 1989 Dec; 80(6 Suppl):IV93-101. PubMed ID: 2513147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.